Patent delisted for Boehringer Ingelheim drug OFEV

Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…

The post Patent delisted for Boehringer Ingelheim drug OFEV appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!